Evaluation of prognostic utility of Ki-67, P53, and O-6-methylguanine-DNA methyltransferase expression in pituitary tumors
BACKGROUND OR CONTEXT: Pituitary adenoma (PA) is the most common pathology of the pituitary gland. Pituitary tumors were historically considered benign, however, from recent advances in pathological and molecular analyses, numerous prognostic markers have been identified, allowing a better character...
Main Authors: | Chhanda Das, Pratap Mondal, Madhumita Mukhopadhyay, Satinath Mukhopadhyay, Ipsita Ghosh, Anusha Handral |
---|---|
Format: | Article |
Language: | English |
Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2019-10-01
|
Series: | Journal of Laboratory Physicians |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.4103/JLP.JLP_76_19 |
Similar Items
-
O6-methylguanine-DNA Methyltransferase Promoter Methylation in Patients with Rectal Adenocarcinoma After Chemoradiotherapy Treatment: Clinical Implications
by: Jaime A. Oliver, et al.
Published: (2019-09-01) -
Neoplasias astrocitárias e correlação com as proteínas p53 mutada e Ki-67 Astrocytic neoplasms and correlation with mutate p53 and Ki-67 proteins
by: Gustavo Rassier Isolan, et al.
Published: (2005-12-01) -
O-6-methylguanine-DNA methyltransferase promoter methylation can change in glioblastoma recurrence due to intratumor heterogeneity
by: Valeria Barresi, et al.
Published: (2018-01-01) -
The Clinical Significance of O6-Methylguanine-DNA Methyltransferase Promoter Methylation Status in Adult Patients With Glioblastoma: A Meta-analysis
by: Yu-Hang Zhao, et al.
Published: (2018-03-01) -
Immunoexpression of Ki-67 and endoglin corroborating hamartomatous nature of sialoangiolipoma
by: Swagatika Panda, et al.
Published: (2017-01-01)